Cancer

Cancer: Presently studies in Pancreas cancer therapy are being conducted in pilot studies to determine the efficacy of a new compound that is reversing the anaerobic metabolism in cancers. We have seen excellent results and remissions in Non Hodgkin’s Lymphoma, Medullary Thyroid Cancers and breast cancer patients with brain metastases. We are also testing new combination therapies and nutrient support for prostate cancer and pancreas patients internationally. Gastrointestinal tumors appeared responsive to these therapies and new work is being planned for lung cancer patients to coincide with one of the exciting new antibodies that activate the Immune system to fight the tumors. This latter antibody has shown itself successful in melanoma and is presently being investigated at multiple Universities for Kidney cancer and lung cancer.